/PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC) The offering of the shares of common stock will be made only by means of a prospectus supplement that forms a part of the registration statement. Biocept down 17% on equity offering (NASDAQ:BIOC ... Mar 05, 2020 · Biocept (BIOC -16.8%) slumps on a 4x surge in volume in reaction to its at-the-market sale of 16M common shares at $0.41 per share (closing price … Biocept, Inc. Common Stock (BIOC) Stock Quotes | Nasdaq Biocept, Inc. Common Stock (BIOC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Biocept (BIOC) Stock Plummets Today After Pricing Public ... Feb 10, 2015 · Shares of Biocept (BIOC) are down after the company announced the pricing of 8 million shares of its common stock and warrants at a combined offering price of $1.25.
Why Biocept, Inc. Stock Is Plunging Today | The Motley Fool
Biocept (BIOC) Stock: Climbing On Expanded Partnership ... Mar 13, 2019 · Biocept Inc (NASDAQ: BIOC) is making a run for the top in the market early on this morning, and for good reason. The company announced that it … A focus on opportunistic stocks: Biocept Inc. (BIOC ... On June 02, 2017, Chardan Capital Markets recommended the BIOC stock is a Buy, while earlier, Chardan Capital Markets had Reiterated the stock as a Buy on November 14, 2017. 1 analysts offering the recommendations for the stock have a consensus rating of 2.00 to suggest that the BIOC stock is a “Moderate Sell”. 0 of the 1 analysts rate the stock as a “Sell”, while 0 has rated it as BIOC Stock News - Fidelity Apr 01, 2020 · Shares of Biocept Inc. (BIOC) plummeted 42% on very heavy volume in morning trading Monday, after the provider of liquid cancer tests announced the pricing of stock offering at a deep discount. The company said it agreed on the issuance and sale of 23 million shares of common stock to several institutional investors, which would increase the BIOC Biocept, Inc. Stock Quote - FINVIZ.com
Mar 26, 2020 · SAN DIEGO, March 2, 2020 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC) ("Biocept" or the "Company"), a leading commercial provider of liquid biopsy tests designed to provide physicians with
Biocept (BIOC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). What Makes Biocept (BIOC) a New Buy Stock - February BIOC - Biocept Labs Summary, Stock Quote and News | Benzinga Jan 01, 2010 · Biocept Labs (NASDAQ: BIOC) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. BIOC Stock News and Price / Biocept, Inc. - Stock Price ... BIOC / Biocept, Inc. 424B5 - Prospectus - 424B5. 03-05 sec.gov Filed pursuant to Rule 424(b)(5) Registration No. 333-224946 PROSPECTUS SUPPLEMENT (To Prospectus dated May 24, 2018) Biocept, Inc. 16,000,000 Shares of Common Stock We are offering 16,000,000 shares of our Common Stock, par value $0.0001 per share (the “Common Stock”), directly to certain institutional accredited investors Biocept - BIOC - Stock Price & News | The Motley Fool Real time Biocept (BIOC) stock price quote, stock graph, news & analysis. Real time Biocept (BIOC) stock price quote, stock graph, news & analysis. The Motley Fool helps millions of people